EP2026657A4 - Anti-cancer composition and method for using the same - Google Patents

Anti-cancer composition and method for using the same

Info

Publication number
EP2026657A4
EP2026657A4 EP07784125A EP07784125A EP2026657A4 EP 2026657 A4 EP2026657 A4 EP 2026657A4 EP 07784125 A EP07784125 A EP 07784125A EP 07784125 A EP07784125 A EP 07784125A EP 2026657 A4 EP2026657 A4 EP 2026657A4
Authority
EP
European Patent Office
Prior art keywords
same
cancer composition
cancer
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07784125A
Other languages
German (de)
French (fr)
Other versions
EP2026657A1 (en
Inventor
Brian C Giles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMAIONIX Inc
Original Assignee
PHARMAIONIX Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMAIONIX Inc filed Critical PHARMAIONIX Inc
Publication of EP2026657A1 publication Critical patent/EP2026657A1/en
Publication of EP2026657A4 publication Critical patent/EP2026657A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
EP07784125A 2006-05-24 2007-05-24 Anti-cancer composition and method for using the same Withdrawn EP2026657A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80808106P 2006-05-24 2006-05-24
US80998406P 2006-06-01 2006-06-01
US87985707P 2007-01-11 2007-01-11
PCT/US2007/069695 WO2007140280A1 (en) 2006-05-24 2007-05-24 Anti-cancer composition and method for using the same

Publications (2)

Publication Number Publication Date
EP2026657A1 EP2026657A1 (en) 2009-02-25
EP2026657A4 true EP2026657A4 (en) 2009-12-09

Family

ID=41278173

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07784125A Withdrawn EP2026657A4 (en) 2006-05-24 2007-05-24 Anti-cancer composition and method for using the same

Country Status (2)

Country Link
EP (1) EP2026657A4 (en)
WO (1) WO2007140280A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2234498A4 (en) * 2007-12-11 2011-02-16 Stephen H Monroe Composition of aqueous buffer solution for the treatment of cellular environment and ion channels and methods for using same
KR20210013542A (en) * 2017-12-21 2021-02-04 빈센트 더블유. 리 Compositions and methods for treating neoplasms
WO2019240706A2 (en) * 2018-01-26 2019-12-19 Demir Caner Cesium dichloroacetate compound to be used in cancer treatment
WO2019236358A1 (en) 2018-06-05 2019-12-12 Peter Novak Rubidium compounds for use in the treatment of cancer
JP2023503127A (en) 2019-11-22 2023-01-26 ベクター・ビターレ・アイピー・リミテッド・ライアビリティ・カンパニー How to prevent the development of melanoma
CN115666593A (en) * 2020-05-21 2023-01-31 国立大学法人大阪大学 Therapeutic agent for epithelial cancer
CN113303476B (en) * 2021-04-23 2022-10-04 中山大学 Application of rubidium salt and rubidium salt solution in preparation of product with prolonged service life and/or anti-aging

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003189A1 (en) * 1992-07-31 1994-02-17 John Lai Therapeutic methods using caesium ions
WO2001015745A1 (en) * 1999-08-31 2001-03-08 Giles Brian C Method and formula for tumor remission and suppression of cancer
KR20020025109A (en) * 2002-01-28 2002-04-03 박동인 a salt grass ointment
US20050244344A1 (en) * 2004-04-12 2005-11-03 Brian Giles Compositions for oral hygiene and method for using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253323A1 (en) * 2003-06-11 2004-12-16 Giles Brian C. Ionic cancer therapy and methods for using same in the treatment of tumors and metastasis
WO2006039504A2 (en) * 2004-10-01 2006-04-13 Cell Ionix, Inc. Method and formulation for stem cells’ stimulation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994003189A1 (en) * 1992-07-31 1994-02-17 John Lai Therapeutic methods using caesium ions
WO2001015745A1 (en) * 1999-08-31 2001-03-08 Giles Brian C Method and formula for tumor remission and suppression of cancer
KR20020025109A (en) * 2002-01-28 2002-04-03 박동인 a salt grass ointment
US20050244344A1 (en) * 2004-04-12 2005-11-03 Brian Giles Compositions for oral hygiene and method for using same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2007140280A1 *

Also Published As

Publication number Publication date
EP2026657A1 (en) 2009-02-25
WO2007140280A1 (en) 2007-12-06

Similar Documents

Publication Publication Date Title
AP2942A (en) Compositions and methods for controlling nematodes
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
EP2039353A4 (en) Reduced coenzyme q10-containing composition and method for producing the same
EP2101731A4 (en) Endoxifen methods and compositions
GB0709781D0 (en) Composition and method
GB0724967D0 (en) Composition and method
EP2173825A4 (en) Ink composition and method for forming the same
EP2088865A4 (en) Guggulphospholipid methods and compositions
EP2026657A4 (en) Anti-cancer composition and method for using the same
HK1183623A1 (en) Antiviral method and composition
EP2132251A4 (en) Composition and method
GB0620930D0 (en) Composition and method for use thereof
GB0625208D0 (en) Composition and method
EP2066433A4 (en) Fluorospar-based filler and method for making the same
EP2065450A4 (en) Crayon and method for producing the same
EP2067832A4 (en) Crayon and method for producing the same
GB0607562D0 (en) Method, composition and use
GB0600261D0 (en) Composition and method
GB0604315D0 (en) Composition and method
SG136084A1 (en) Adhesive composition and method for producing the same
GB0607488D0 (en) Composition and process
GB0605004D0 (en) Composition and process
GB0607493D0 (en) Composition and process
TWI369180B (en) Corpse-treatment composition and corpse-treatment method
GB0621096D0 (en) Composition and method

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081223

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20091109

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 35/00 20060101ALI20091103BHEP

Ipc: A61P 31/00 20060101ALI20091103BHEP

Ipc: A61P 29/00 20060101ALI20091103BHEP

Ipc: A61P 17/02 20060101ALI20091103BHEP

Ipc: A61P 17/00 20060101ALI20091103BHEP

Ipc: A61K 45/06 20060101ALI20091103BHEP

Ipc: A61K 33/00 20060101AFI20091103BHEP

17Q First examination report despatched

Effective date: 20100212

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120811